As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...] …
Articles by : Bella Czajkowski, National Correspondent
A coalition of national and local hospital advocacy groups recently filed briefs in multiple federal lawsuits: One that supports the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Florida providers are concerned that a new state bill, which aims to lower Medicaid prices in the state, could significantly [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After almost cancelling the vote in a last minute search for support, U.S. House Majority Leader Mike Johnson (R-La.) muscled [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After the Health Resources and Services Administration (HRSA) canceled its annual 340B grantee recertification webinar amid disruptions from a federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Conservative groups and advocates have recently ramped up efforts to combat the growing number of state 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California-based 340B hospital that sued the federal government for denying its 340B access has dropped the lawsuit after being [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent study suggested that 340B providers prescribe more drugs for treating breast cancer, but do not have any significant [...] …